,
Bousema, Jelle E.
Dijkgraaf, Marcel G. W.
Papen-Botterhuis, Nicole E.
Schreurs, Hermien W.
Maessen, Jos G.
van der Heijden, Erik H.
Steup, Willem H.
Braun, Jerry
Noyez, Valentin J. J. M.
Hoeijmakers, Fieke
Beck, Naomi
van Dorp, Martijn
Claessens, Niels J. M.
Hiddinga, Birgitta I.
Daniels, Johannes M. A.
Heineman, David J.
Zandbergen, Harmen R.
Verhagen, Ad F. T. M.
van Schil, Paul E.
Annema, Jouke T.
van den Broek, Frank J. C.
Funding for this research was provided by:
ZonMw (843004109)
KWF Kankerbestrijding (11313)
Article History
Received: 22 March 2018
Accepted: 2 May 2018
First Online: 18 May 2018
Ethics approval and consent to participate
: The medical ethical committee of the Maxima Medical Center has approved the study protocol and all participating centers (MEC number W17.063) on June, 15th, 2017. All participating centers signed the research contract prior to start inclusion. Before randomization, written informed consent will be obtained from all patients.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.